Clinical-to-Lab Integration
Direct access to institutional clinical insights accelerates target identification and structural disease mapping.
// Lifeline Health • The life-sciences division of Lifeline Hospitals (Pty) Ltd
Decoding disease.Designing therapeutics.
Bridging frontline clinical excellence with advanced molecular biology. Lifeline Health applies computational modeling and advanced viral vector platforms to develop targeted treatments for the world's most critical medical challenges.
Corporate Architecture
Lifeline Health operates as the dedicated biopharmaceutical and research division of Lifeline Hospitals (Pty) Ltd.
While our medical facilities deliver elite patient care on the frontline, Lifeline Health works in the laboratory, translating complex clinical insights into next-generation regenerative cell-signaling therapies.
Translational Medicine
A streamlined ecosystem moves proprietary molecular discoveries from chemical synthesis through structured pre-clinical validation.
Institutional Framework
Backed by the healthcare infrastructure and corporate governance of Lifeline Hospitals (Pty) Ltd.
LHP-26
Flagship Program
Lab-Stage
Current Phase
04
Core Research Areas
2026
Facility Opening
We operate at the intersection of advanced virology, precision chemical synthesis, and molecular biology to transition breakthrough science from laboratory research into scalable, life-changing therapeutic applications.
Targeted Precision
Developing advanced delivery mechanisms engineered for cellular-level accuracy and optimal therapeutic indices.
Scientific Validation
Collaborating with leading scientific institutions and genetics experts to ensure rigorous chemical synthesis, benchmarking, and replication.
Commercial Scalability
A robust intellectual property pipeline structured for high-impact market entry, venture readiness, and long-term investor alignment.
Project Genesis
Project Genesis: The Future of Biologics.
Deep-dive technical architecture and development pipeline of our lead therapeutic candidate, LhP-26.
The Paradigm Shift
Project Genesis represents a departure from traditional, reactive treatment modalities. By leveraging precise molecular biology, our research focuses on proprietary cell-signaling pathways to activate natural regenerative mechanisms and targeted cellular defenses.
Operational Ecosystem
Our development framework integrates rigorous chemical synthesis with state-of-the-art genetics and molecular biology research. This streamlined pipeline ensures every milestone is backed by verifiable, clinical-grade data from initial pitch validation to secure data transfer.
PhaseFocus AreaStatus
Phase IMolecular Discovery & Initial SynthesisComplete
Phase IIAdvanced In-Vitro Validation & Virology EfficacyIn Progress
Phase IIIPre-Clinical Scale-Up & Regulatory FilingUpcoming
Therapeutic Horizons
Expanding the Horizons of Targeted Therapeutics.
Translating our proprietary cell-signaling platform to address the world’s most critical unmet medical needs: Oncology and Neurodegeneration.
Our core scientific breakthrough is not limited to a single therapeutic area. The foundational cell-signaling and advanced virology mechanisms driving our current research serve as a modular platform engineered to be reprogrammed for diverse, complex clinical indications.
Horizon 01
Molecular Oncology
Cancer Targeted Therapy
- The Challenge
- Traditional oncology treatments often suffer from a lack of cellular specificity, damaging healthy tissue alongside malignant cells.
- Our Approach
- Leveraging advanced virology techniques and cell-signaling architectures to design bio-engineered vectors programmed to selectively identify, target, and disrupt signaling pathways exclusive to oncogenic cells.
- Status
- Concept Validation & Target Identification
Horizon 02
Neurodegenerative Therapeutics
Alzheimer’s Disease
- The Challenge
- Overcoming the blood-brain barrier to effectively halt cellular degradation and neural inflammation.
- Our Approach
- Applying proprietary regenerative signaling mechanisms to promote neural cell survival and mitigate neuro-inflammation while adapting molecular delivery platforms for early micro-environmental targeting.
- Status
- Exploratory Research & Platform Adaptation
Investor Strategy
De-Risking Discovery Through Platform Scalability.
By developing a versatile platform rather than isolated assets, Lifeline maximizes therapeutic reach while optimizing R&D efficiency. Investors benefit from a diversified asset pipeline built upon a unified, validated scientific foundation, significantly accelerating the timeline from conceptual discovery to pre-clinical validation.
Interested in co-developing or reviewing our early-stage pipeline data?
Request Secure Data Room AccessLeadership & Scientific Advisory
The Minds Driving the Innovation.
A specialized syndicate of innovators, clinical researchers, and legal strategists dedicated to pioneering regenerative therapeutics.
Neo M.
Chief Executive Officer & Founder
- Focus
- Strategic corporate direction, portfolio commercialization, and cross-disciplinary medical technology innovation.
- Executive Bio
- Leading the strategic vision of Lifeline to transition proprietary cell-signaling platforms from high-level institutional validation into scalable global therapeutic applications.
Amanda Fourie
Chief Legal Officer & General Counsel
- Focus
- Global intellectual property strategy, regulatory compliance, and institutional frameworks.
- Executive Bio
- Coordinates secure data transfers, manages provisional patent registries, and ensures rigorous compliance with regulatory bodies to protect Lifeline’s proprietary biotech assets and investor interests.
Yolandii Mabaso
Head of Molecular Virology & Genetics
- Focus
- Advanced cellular-signaling tracking, viral vector platforms, and in-vitro efficacy.
- Executive Bio
- Leads the core scientific team in mapping complex cellular structures, developing precise delivery mechanisms for biological candidates, and managing laboratory scaling of foundational discovery platforms.
Cameron Smith
Director of Research & Development (R&D)
- Focus
- Precision chemical synthesis, computational modeling, and therapeutic pipeline expansion.
- Executive Bio
- Oversees milestone progression from initial molecular synthesis into validation phases, translating platform technology into scalable candidates for oncology and neurodegenerative therapeutic horizons.
Rigorous Governance. Absolute Compliance.
To protect proprietary discovery mechanisms, provisional patent integrity, and institutional data pipelines, our complete clinical execution team operates under strict non-disclosure frameworks. Detailed curriculum vitaes, publication histories, and operational track records for our complete technical committee are available to vetted institutional investors within our secure data room.
Request Credentials & Data Room AccessInvestor Gateway
Secure Inquiries & Strategic Partnerships.
Lifeline is currently engaging with institutional investors, healthcare venture funds, and strategic clinical partners who share our vision for disruptive biomedical innovation. Access to our secure data room, provisional patent details, and full technical whitepapers is available to verified parties upon execution of a Non-Disclosure Agreement (NDA).
Secure transfer protocols and legal review are enforced for all institutional communications.
// Lifeline Hospitals
A new home for healthcare. Opening 2026.
We can't wait to meet you, South Africa. Our flagship facility brings clinical care and life-sciences innovation under one roof.
Status
Under construction
Opening
2026
Location
South Africa
// Careers
Build the future of healthcare with us.
We're assembling a team of scientists, clinicians and operators who want their work to matter. If that's you, we'd like to hear from you.
// Contact
Let's talk.
Whether you're a research partner, prospective hire or have a general enquiry, reach the right team directly.
Office & WhatsApp
061 152 7878
Primary office line & WhatsApp
General Enquiries
info@lifelinehealth.co.za
Scientific Division
virology@lifelinehealth.co.za
Legal & IP Governance
legal@lifelinehealth.co.za
Human Resources
hr@lifelinehealth.co.za